INTEGRININHIBITOREN
European patent · EP4086254 · Deleted
Register entry
- Publication number
- EP4086254
- Application number
- EP22173105
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Aug 29, 2019
- Published
- Nov 9, 2022
- Granted
- Dec 18, 2024
- Deleted
- Mar 24, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07D 471/04 (2006.01)A61K 31/4375 (2006.01)A61P 11/00 (2006.01)
- Priority
- US 201862724423 P 29.08.2018US 201962859457 P 10.06.2019
- Divided from
- EP19194490
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 24, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 24.03.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 24.03.2026
- Oct 29, 2025
Change
Published in Swissreg on 29.10.2025
- Dec 18, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 18.12.2024
Parties
Inventor
Framingham, 01704, US
Lexington, 02420, US
Needham, 02494, US
Bedford, 01730, US
Newton Center, 02459-1134, US
Belmont, 02478, US
Medford, 02155, US
Belmont, 02478, US
Natick, 01760, US
Chestnut Hill, 02467, US
Cambridge, 02139, US
Flemington, 08822, US
Metuchen, 08840, US
New York, 10011, US
Danbury, 06811, US
Brooklyn, 11215, US
New York, 10036, US
West New York, 07093, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.